Core Insights - S&P Dow Jones Indices has launched SPICE® IndexBuilder™, a self-service platform for designing, testing, and ordering custom indices, aimed at enhancing client-led innovation and reducing time-to-market [1][2]. Group 1: Product Features - SPICE IndexBuilder allows users to prototype, backtest, analyze, and order customized index solutions within a unified interface [1]. - The platform provides access to S&P DJI's extensive library of index attributes, enabling comprehensive customization of existing indices or bespoke solutions [6]. - Users can customize key parameters such as return types, currencies, weighting methodologies, and exclusions to align with specific investment strategies [6]. Group 2: Strategic Importance - The introduction of SPICE IndexBuilder reflects S&P DJI's commitment to empowering clients with professional-grade index creation tools, enhancing flexibility while ensuring data quality [2]. - Custom indexing is increasingly critical for investors implementing specific strategies, and this platform supports innovation across diverse asset classes and geographies [4][2]. Group 3: Operational Efficiency - The platform enables fast backtesting, allowing users to generate detailed historical performance analytics quickly, facilitating swift evaluation of index concepts [6]. - Clients can submit index creation requests with a single click once finalized, which accelerates the time-to-market for new indices [6].

Investment Rating - Industry Rating: Overweight [1] Core Views - The chemical sector showed a weekly performance ranking of 8th with a gain of 1.99%, outperforming the Shanghai Composite Index by 1.63 percentage points and the ChiNext Index by 5.85 percentage points [4][22]. - The chemical industry is expected to continue its differentiated trend in 2025, with recommendations to focus on synthetic biology, pesticides, chromatography media, sweeteners, vitamins, light hydrocarbon chemicals, COC polymers, and MDI [4]. Summary by Sections Industry Performance - The chemical sector's overall performance for the week of October 9-10, 2025, was a gain of 1.99%, ranking 8th among sectors [22]. - The top three performing sub-sectors were phosphate and phosphorus chemicals (6.26%), titanium dioxide (4.23%), and oil and petrochemical trade (4.23%) [23]. Key Industry Dynamics - Synthetic biology is at a pivotal moment, with low-energy products expected to gain a longer growth window due to the adjustment of energy structures [4]. - The upcoming quota policy for third-generation refrigerants is anticipated to enter a high prosperity cycle, with demand expected to grow steadily due to market expansion in Southeast Asia [5]. - The electronic specialty gases market is characterized by high technical barriers and high added value, with significant opportunities for domestic substitution [6][8]. - The trend of light hydrocarbon chemicals is becoming global, with a shift towards lighter raw materials for olefin production [8]. - The COC polymer industry is accelerating its domestic industrialization process, driven by supply chain security concerns and the shift of downstream industries to domestic production [9]. - Potash fertilizer prices are expected to rebound as major producers reduce output and the demand for fertilizers increases due to rising grain prices [10]. - The MDI market is characterized by oligopoly, with a favorable supply structure expected as demand gradually recovers [12].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with a focus on misleading statements regarding the company's financial health and ability to manage macroeconomic challenges [1][4]. Company Overview - Dow Inc. provides materials science solutions across various sectors, including packaging, infrastructure, mobility, and consumer applications [3]. Allegations of the Lawsuit - The lawsuit claims that Dow and its executives made false or misleading statements about the company's financial flexibility and ability to handle macroeconomic and tariff-related challenges [4]. - It is alleged that Dow understated the negative impacts of competitive pressures, softening global sales, and product oversupply on its business [4]. Financial Performance - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00 due to ongoing weakness in key markets [5]. - Following this downgrade, Dow's stock price fell by over 3% [5]. - On July 24, 2025, Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18 per share, with net sales of $10.1 billion, a 7.3% year-over-year decline [6]. - Dow's CEO attributed the disappointing results to a challenging earnings environment and announced a dividend cut from $0.70 to $0.35 per share, leading to a stock price drop of over 17% [6]. Legal Process - Investors who purchased Dow securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to represent the interests of all class members [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - A class action lawsuit has been filed against Dow, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial condition during the specified class period from January 30, 2025, to July 23, 2025 [1][7]. Allegation Details - Defendants overstated Dow's ability to manage macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [3]. - The negative impacts of competitive pressures, softening global sales, and product oversupply on Dow's business were understated [3]. - Public statements made by the defendants were materially false and misleading throughout the class period [3]. Next Steps - Investors who purchased Dow shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28, 2025 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation [5]. - The firm has offices in New York, California, and South Carolina, and handles cases in state and federal courts across the country [5].

Core Viewpoint - Dow, Inc. is facing a class action lawsuit from investors who purchased securities during the specified class period, following disappointing financial results and a significant drop in stock price [1][3]. Financial Performance - For Q2 2025, Dow reported net sales of $10.1 billion, which represents a 7% decline year-over-year and a 3% decrease sequentially [3]. - The decline in net sales was attributed to decreases across all operating segments, despite seasonally higher demand in Performance Materials & Coatings [3]. - Following the financial results announcement, Dow's stock price fell by $5.30 per share, equating to a 17.45% drop, closing at $25.07 per share on July 24, 2025 [3]. Legal Actions - Investors are encouraged to file a lead plaintiff motion by October 28, 2025, to participate in the class action lawsuit [1]. - The Portnoy Law Firm is offering complimentary case evaluations to investors seeking to recover losses due to corporate wrongdoing [2][4].

Core Points - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, about the lead plaintiff deadline of October 28, 2025 [1][2] - Investors may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs [1][2] Case Details - The lawsuit alleges that Dow made false and misleading statements regarding its ability to handle macroeconomic and tariff-related challenges, overstating its financial flexibility to support dividends [4] - It is claimed that the negative impacts of competitive pressures, softening global sales, and product oversupply were understated, leading to materially false public statements [4] - The lawsuit asserts that when the true details became known, investors suffered damages [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [3] - Rosen Law Firm has a history of significant settlements and has been recognized for its performance in securities class actions [3]

Core Points - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, of the October 28, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Group 1: Class Action Details - A class action lawsuit has been filed against Dow Inc. for allegedly making false and misleading statements regarding its financial condition and ability to manage macroeconomic challenges [4] - The lawsuit claims that Dow overstated its ability to mitigate macroeconomic and tariff-related headwinds, and understated the negative impacts of competitive pressures, softening global sales, and product oversupply [4] - Investors are encouraged to join the class action by submitting a form or contacting the law firm for more information [2][5] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360 [3]

Core Viewpoint - The Gross Law Firm is notifying shareholders of Dow Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from January 30, 2025, to July 23, 2025 [3]. - Allegations include that Dow Inc. overstated its ability to manage macroeconomic and tariff-related challenges, and failed to adequately disclose the negative impacts of these challenges on its business and financial condition [3]. Financial Implications - The complaint suggests that Dow's public statements were materially false and misleading, particularly regarding competitive pressures, declining global sales, and an oversupply of products in the market [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by October 28, 2025, to potentially be appointed as lead plaintiffs [4]. - Once registered, shareholders will receive updates on the case through portfolio monitoring software [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [5].

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to consider their financial situation and needs before relying on the information provided [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to perform their own research and understand the risks involved before investing in any financial instruments [1].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with claims that the company misrepresented its financial health and ability to manage macroeconomic challenges during a specified class period [1][3]. Summary by Sections Class Action Lawsuit Details - The lawsuit, titled Sarti v. Dow Inc., allows purchasers of Dow securities from January 30, 2025, to July 23, 2025, to seek lead plaintiff status by October 28, 2025 [1]. - The allegations include that Dow overstated its ability to handle macroeconomic and tariff-related challenges and understated the negative impacts on its business [3]. Financial Performance and Market Reactions - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, citing ongoing weakness in key markets [4]. - Following this downgrade, Dow's stock price fell by over 3% [4]. - On July 24, 2025, Dow reported a non-GAAP loss per share of $0.42, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline [5]. - Dow's CEO attributed the disappointing results to a challenging earnings environment and announced a dividend cut from $0.70 to $0.35 per share, leading to a stock price drop of over 17% [5]. Legal Process for Lead Plaintiff - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Dow securities during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [6]. About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7].